Biography


Biography

<< Back

Mohammad Azab

Director
Dr. Azab has served as a member of our Board since October 2003. In July 2009, Dr. Azab joined Astex Pharmaceuticals, Inc., a pharmaceutical company focused on the discovery and development of drugs in oncology and other areas, as its Chief Medical Officer. Dr. Azab served as President and Chief Medical Officer of Astex from January 2014 to November 2020, and has since been serving as the Chair of Board of Directors. Since June 2021, Dr. Azab has served on the Board of Directors for Sernova Corp., a publicly traded, clinical-stage regenerative medicine therapeutics company. And, since January 2021, Dr. Azab has served on the Board of Directors of Durect Corporation, a publicly traded biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases. Previously, Dr. Azab served as President and CEO of Intradigm Corporation, a developer of siRNA cancer therapeutics. Prior to this, Dr. Azab served as Executive Vice President of Research and Development, and Chief Medical Officer of QLT Inc., and in several leadership positions at Astra Zeneca in the United Kingdom and Sanofi Pharmaceuticals in France. Dr. Azab holds an M.B.A. from the Richard Ivey School of Business, University of Western Ontario, and an MB ChB from Cairo University. He received post-graduate training and degrees in oncology research from the University of Paris-Sud and biostatistics from the University of Pierre et Marie Curie in Paris, France.